Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2497352PMC

Publication Analysis

Top Keywords

polypill polymeal
4
polymeal nhf's
4
nhf's view
4
view wonder
4
wonder drugs
4
polypill
1
nhf's
1
view
1
wonder
1
drugs
1

Similar Publications

The reality of primary and secondary prevention of cardiovascular complications in people with diabetes is alarming, even in developed countries with a well-structured medical system. Even though therapeutic targets have been more clearly defined during the last decades, their implementation is still suboptimal. Financial and structural reasons, insufficient information of physicians and patients, along with a low compliance of the latter are only a few reasons that have been incriminated.

View Article and Find Full Text PDF

The future of metabolic syndrome and cardiovascular disease prevention: polyhype or polyhope? Tales from the polyera.

Horm Metab Res

September 2007

Unilever Corporate Research, Colworth Park, Sharnbrook, Bedfordshire, MK441LQ, UK.

Recently society has been witnessing the rise of a new era in the prevention and treatment of the metabolic syndrome and cardiovascular disease: the Polyera. This new era started when a promising concept - the Polypill - was introduced by Wald et al. in 2003.

View Article and Find Full Text PDF

Objective: Although the Polypill concept (proposed in 2003) is promising in terms of benefits for cardiovascular risk management, the potential costs and adverse effects are its main pitfalls. The objective of this study was to identify a tastier and safer alternative to the Polypill: the Polymeal.

Methods: Data on the ingredients of the Polymeal were taken from the literature.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!